Pursuant to the provisions of Reg., 30(6) of the SEBI (LODR) Reg., 2015, we would like to inform you that at the meeting of Board of Directors of M/s Phyto Chem (India) Limited held on 13-08-26, the Board has approved inter-alia the following items: 1. Approved the Unaudited Financial Results of the company for the 1st Quarter ended 30-06-26. 2. Approved the re-appointment of M/s R. B. Associates., Chartered Accountants as the Internal Auditors of the Company for the F.Y. 2026-27. 3. Approved the Directors' Report and Report on Corporate Governance, Notice and Appointment of Scrutinizer for the F.Y. 2025-26. 4. Approved the Date and Venue, Dates for Book Closure and cut off dates and e-voting system for 37th AGM of the Company. 5. Approved to lease out spare manufacturing facilities for effective utilisation. The details required under Reg., 30 of the LODR read with as per SEBI Circular are provided in Annexure-A to this letter.

Approval of Un audited Financial Results for Quarter ended June 30, 2026

A Meeting of the Board of Directors of the Company was held as scheduled today, i.e. 13th August, 2026 and the Board inter-alia took the following decisions: 1. Considered and approved the unaudited financial results (standalone and consolidated) of the Company for the First quarter ended 30th June, 2026 along with the Limited Review Report issued by M/s. S.R. Batliboi & Associates LLP, Statutory Auditors of the Company. The financial results are enclosed pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company approved the allotment of 3,000 equity shares to those employees who have exercised their options for equity shares under the Centum - Restricted Stock Unit Plan 2021. The paid-up equity share capital of the Company has increased from Rs. 14,75,90,160 /- to Rs. 14,76,20,160/- due to the aforesaid allotment.

Financial Results for quarter ended June 30,2026.

Board Meeting for Approval of Unaudited Standalone Financial Results for the Quarter ended on June 30, 2026.

Submission of Un-audited Financial Results for the Quarter ended on 30.06.2026

Outcome of Board Meeting held today i.e 13th August, 2026 for approval of Unaudited Standalone and Consolidated Financial Results for the quarter ended on 30th June, 2026

Approved and taken on record Un-Audited Standalone and Consolidated Financial Results for the Quarter ended on June 30, 2026, along with Limited Review Report.

UNAUDITED STANDALONE & CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED 30.06.2026

Submission of quarterly results